Cellectar Biosciences, Inc. (CLRB) vs Optimi Health Corp. (OPTH)
A side-by-side comparison of Cellectar Biosciences, Inc. and Optimi Health Corp. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CLRB
Cellectar Biosciences, Inc.
$1.62HealthcareDelayed quote: Oct 6, 2026, 1:50 PM EDT
OPTH
Optimi Health Corp.
$4.20HealthcareDelayed quote: Oct 6, 2026, 1:47 PM EDT
Total return — CLRB vs OPTH
growth of $100 · dividends reinvested · last 6yCLRB -99.5% (-58.1%/yr)OPTH -74.5% (-20.4%/yr)OPTH compounded faster over this window
Log scale — wide-divergence pair
CLRB OPTH
CLRB vs OPTH: by the numbers
- •OPTH is the larger company ($14M vs $13M market cap).
- •Both run net losses; CLRB's is the smaller (0.00% vs -3972.87% net margin).
Metrics side by side
Valuation
| Metric | CLRB | OPTH |
|---|---|---|
| P/S ratio | N/A | 108.72 |
| P/B ratio | 0.43 | 1.09 |
Profitability
| Metric | CLRB | OPTH |
|---|---|---|
| Gross margin | 0.00% | -486.44% |
| Operating margin | 0.00% | -1062.29% |
| Net margin | 0.00% | -3972.87% |
| ROE | -74.73% | -39.76% |
| ROIC | -74.94% | -28.72% |
Growth (annualized)
| Metric | CLRB | OPTH |
|---|---|---|
| Total return CAGR (5Y) | -60.51% | -21.80% |
Frequently asked
- How have CLRB and OPTH total returns compared?
- Over the past 5 years, CLRB delivered -60.51% and OPTH delivered -21.80% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.